Screener
R&D
Breakdown
Segments
Expense for other preclinical and research programsView metric
ZanidatamabView metric
ZW171View metric
ZW191View metric
ZW220View metric
ZW251View metric
| Segment | Q1 '26 | Q2 '26 |
|---|---|---|
| Expense for other preclinical and research programs | $7.26M | $4.19M |
| ZW251 | $1.91M | $3.21M |
| ZW191 | $3.03M | $3.13M |
| Zanidatamab | $623K | $2.18M |
| ZW171 | $1.15M | -$458K |
| ZW220 | $97K | -$152K |
| Total | $34.46M | $27.44M |